GILD

NASDAQ · Biotechnology

Gilead Sciences Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$129.58

-2.48 (-1.88%)

As of May 16, 1:01 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 31 79%

Hold 8 21%

Sell 0 0%

Price Target

Analyst Price Target +179.9% upside

Low Target $213.16

Average Target $362.68

High Target $477.67

Current Price $129.58

Current
$129.58

Target
$362.68

$213.16 $362.68 avg $477.67

Scenario Analysis

Bear Case

$213.16

64.5%

Low target

Base Case

$362.68

+179.9%

Avg target

Bull Case

$477.67

+268.6%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$157.29

-17.6% from high

52-Week Low

$97.86

+32.4% from low

50-Day SMA

$131.98

-1.8% vs SMA

200-Day SMA

$118.67

+9.2% vs SMA

RSI (14)

65.1

Neutral

Target vs 52W High

$362.68

+130.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%